A simple pill could prevent sight loss in diabetes-driven eye condition, early findings suggest

Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication ("Danegaptide") can protect against vision-threatening damage in nonproliferative diabetic retinopathy (NPDR), a leading cause of blindness in working-age adults.

Read it at Medical Xpress ↗

← Front page